KRAS and colorectal carcinoma: Hypermutated EOCRC tumors exhibit higher tumor mutational burden (TMB) and a higher prevalence of somatic variants in APC, KRAS, CTNNB1, and TCF7L2, while BRAF and RNF43 variants are less frequent compared to late-onset hypermutated CRC [3].